Achilles Therapeutics plc announced the appointment of Bernhard Ehmer, MD, to the Board as a Non-Executive Director. Bernhard joins Achilles with a strong track record in international R&D, regulatory and commercial activities. He most recently served as CEO of Biotest AG in Germany and also served as chairman of the board of directors at Symphogen A/S, Denmark until its acquisition by Servier SA in June 2020.

Achilles also announced that Derek DiRocco of RA Capital Management has resigned from the Board of Directors effective May 3, 2022.